Christopher Ryan Miller

UNCCH, School of Medicine, Pathology and Laboratory Medicine

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Christopher Ryan Miller

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Pathology and Laboratory Medicine
  
  

Help us refine your profile

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Li-Jun Di; Jung S. Byun; Madeline M. Wong; Clay Wakano; Tara Taylor; Sven Bilke; Songjoon Baek; Kent Hunter; Howard Yang; Maxwell Lee; et al.

  Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer

  Nature Communications. 2013;4.
  1

• 2.

  2013

  Aditya Raghunathan; Khalida Wani; Terri S. Armstrong; Elizabeth Vera-Bolanos; Maryam Fouladi; Richard Gilbertson; Amar Gajjar; Stewart Goldman; Norman L. Lehman; Phillipe Metellus; et al.

  Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System

  Brain Pathology. 2013.
  0

• 3.

  2012

  Evan S. Dellon; Xiaoxin Chen; C Ryan Miller; John T. Woosley; Nicholas J. Shaheen

  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis

  American Journal of Gastroenterology. 2012;107(10):1503-1511.
  5

• 4.

  2012

  I Garcia; A J Crowther; V Gama; C Ryan Miller; M Deshmukh; T R Gershon

  Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation

  Oncogene. 2012.
  1

• 5.

  2012

  Wenjin Liu; Kimberly B. Monahan; Adam D. Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T. Chan; David W. Roadcap; David W. Ollila; Nancy E. Thomas; Diego H. Castrillon; et al.

  LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma

  Cancer Cell. 2012;21(6):751-764.
  5

• 6.

  2012

  Matthew D. Wilkerson; Xiaoying Yin; Vonn Walter; Ni Zhao; Christopher R. Cabanski; Michele C. Hayward; C. Ryan Miller; Mark A. Socinski; Alden M. Parsons; Leigh B. Thorne; et al.

  Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

  PLoS ONE. 2012;7(5).
  3

• 7.

  2012

  Ralf S. Schmid; Mark Vitucci; C. Ryan Miller

  Genetically engineered mouse models of diffuse gliomas

  Brain Research Bulletin. 2012;88(1):72-79.
  1

• 8.

  2012

  Yanxin Pei; Colin E. Moore; Jun Wang; Alok K. Tewari; Alexey Eroshkin; Yoon-Jae Cho; Hendrik Witt; Andrey Korshunov; Tracy-Ann Read; Julia L. Sun; et al.

  An Animal Model of MYC-Driven Medulloblastoma

  Cancer Cell. 2012;21(2):155-167.
  23

• 9.

  2012

  E.S. Dellon; J.J. Bower; T.O. Keku; X. Chen; C.R. Miller; J.T. Woosley; R.C. Orlando; N.J. Shaheen

  Markers of tyrosine kinase activity in eosinophilic esophagitis: A pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5

  Diseases of the Esophagus. 2012;25(2):166-174.
  1

• 10.

  2012

  Li Ding; Timothy J. Ley; David E. Larson; Christopher A. Miller; Daniel C. Koboldt; John S. Welch; Julie K. Ritchey; Margaret A. Young; Tamara Lamprecht; Michael D. McLellan; et al.

  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

  Nature. 2012;481(7382):506-510.
  105

• 11.

  2011

  Barbara Adamo; Allison M. Deal; Emily Burrows; Joseph Geradts; Erika Hamilton; Kimberly L. Blackwell; Chad Livasy; Karen Fritchie; Aleix Prat; J C. Harrell; et al.

  Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases

  Breast Cancer Research. 2011;13(6).
  4

• 12.

  2011

  Laurence D. Parnell; Pierre Lindenbaum; Khader Shameer; Giovanni Marco Dall'Olio; Daniel C. Swan; Lars Juhl Jensen; Simon J. Cockell; Brent S. Pedersen; Mary E. Mangan; Christopher A. Miller; et al.

  BioStar: An online question & answer resource for the bioinformatics community

  PLoS Computational Biology. 2011;7(10).
  3

• 13.

  2011

  Oliver A. Hampton; Christopher A. Miller; Maxim Koriabine; Jian Li; Petra Den Hollander; Lucia Carbone; Mikhail Nefedov; Boudewijn F.H. Ten Hallers; Adrian V. Lee; Pieter J. De Jong; et al.

  Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines

  Cancer Genetics. 2011;204(8):447-457.
  4

• 14.

  2011

  Carey K. Anders; Allison M. Deal; C. Ryan Miller; Carmen Khorram; Hong Meng; Emily Burrows; Chad Livasy; Karen Fritchie; Matthew G. Ewend; Charles M. Perou; et al.

  The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

  Cancer. 2011;117(8):1602-1611.
  13

• 15.

  2011

  M. Vitucci; D.N. Hayes; C.R. Miller

  Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy

  British Journal of Cancer. 2011;104(4):545-553.
  22

• 16.

  2011

  Evan S. Dellon; Xiaoxin Chen; C Ryan Miller; Karen J. Fritchie; Tara C. Rubinas; John T. Woosley; Nicholas J. Shaheen

  Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease

  American Journal of Gastroenterology. 2011;106(2):264-271.
  20

• 17.

  2011

  Craig Horbinski; C Ryan Miller; Arie Perry

  Gone FISHing: Clinical lessons learned in brain tumor molecular diagnostics over the last decade

  Brain Pathology. 2011;21(1):57-73.
  11

• 18.

  2011

  Christopher A. Miller; Oliver Hampton; Cristian Coarfa; Aleksandar Milosavljevic

  ReadDepth: A parallel R package for detecting copy number alterations from short sequencing reads

  PLoS ONE. 2011;6(1).
  12

• 19.

  2011

  Christopher A Miller; Stephen H Settle; Erik P Sulman; Kenneth D Aldape; Aleksandar Milosavljevic

  Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors

  BMC Medical Genomics. 2011;4.
  3

• 20.

  2010

  Cristian Coarfa; Fuli Yu; Christopher A. Miller; Zuozhou Chen; R Alan Harris; Aleksandar Milosavljevic

  Pash 3.0: A versatile software package for read mapping and integrative analysis of genomic and epigenomic variation using massively parallel DNA sequencing

  BMC Bioinformatics. 2010;11.
  9

• 21.

  2010

  Matthew D. Wilkerson; Xiaoying Yin; Katherine A. Hoadley; Yufeng Liu; Michele C. Hayward; Christopher R. Cabanski; Kenneth Muldrew; C. Ryan Miller; Scott H. Randell; Mark A. Socinski; et al.

  Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types

  Clinical Cancer Research. 2010;16(19):4864-4875.
  15

• 22.

  2010

  Roel G.W. Verhaak; Katherine A. Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D. Wilkerson; C. Ryan Miller; Li Ding; Todd Golub; Jill P. Mesirov; et al.

  Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

  Cancer Cell. 2010;17(1):98-110.
  624

• 23.

  2009

  Boone Goodgame; Avinash Viswanathan; Jennifer Zoole; Feng Gao; C Ryan Miller; Janakiraman Subramanian; Bryan F. Meyers; Alexander G. Patterson; Ramaswamy Govindan

  Risk of recurrence of resected stage i non-small cell lung cancer in elderly patients as compared with younger patients

  Journal of Thoracic Oncology. 2009;4(11):1370-1374.
  17

• 24.

  2009

  Oliver A. Hampton; Petra Den Hollander; Christopher A. Miller; David A. Delgado; Jian Li; Cristian Coarfa; Ronald A. Harris; Stephen Richards; Steven E. Scherer; Donna M. Muzny; et al.

  A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome

  Genome Research. 2009;19(2):167-177.
  54

• 25.

  2009

  Arie Perry; C. Ryan Miller; Meena Gujrati; Bernd W. Scheithauer; Sandro Casavilca Zambrano; Sarah C. Jost; Ravi Raghavan; Jiang Qian; Elizabeth J. Cochran; Jason T. Huse; et al.

  Malignant gliomas with primitive neuroectodermal tumor-like components: A clinicopathologic and genetic study of 53 cases

  Brain Pathology. 2009;19(1):81-90.
  33

• 26.

  2008

  Roger McLendon; Allan Friedman; Darrell Bigner; Erwin G. Van Meir; Daniel J. Brat; Gena M. Mastrogianakis; Jeffrey J. Olson; Tom Mikkelsen; Norman Lehman; Ken Aldape; et al.

  Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  Nature. 2008;455(7216):1061-1068.
  1494

• 27.

  2008

  Dimitri Trembath; Christopher Ryan Miller; Arie Perry

  Gray zones in brain tumor classification: Evolving concepts

  Advances in Anatomic Pathology. 2008;15(5):287-297.
  11

• 28.

  2008

  Boone Goodgame; Avinash Viswanathan; C. Ryan Miller; Feng Gao; Bryan Meyers; Richard J. Battafarano; Alexander Patterson; Joel Cooper; Tracey J. Guthrie; Jeffrey Bradley; et al.

  A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer

  American Journal of Clinical Oncology: Cancer Clinical Trials. 2008;31(1):22-28.
  8

• 29.

  2007

  Marjo V. Smith; Chris R. Miller; Michael Kohn; Nigel J. Walker; Chris J. Portier

  Absolute estimation of initial concentrations of amplicon in a real-time RT-PCR process

  BMC Bioinformatics. 2007;8.
  9

• 30.

  2007

  L. Yuan; M. Siegel; K. Choi; C. Khosla; C.R. Miller; E.N. Jackson; D. Piwnica-Worms; K.M. Rich

  Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy

  Oncogene. 2007;26(18):2563-2573.
  65

• 31.

  2007

  W.T. Lim; W.H. Zhang; C.R. Miller; J.W. Watters; F. Gao; A. Viswanathan; R. Govindan; H.L. McLeod

  PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.

  Oncology reports. 2007;17(4):853-857.
  38

• 32.

  2007

  C. Ryan Miller; Arie Perry

  Glioblastoma: Morphologic and molecular genetic diversity

  Archives of Pathology and Laboratory Medicine. 2007;131(3):397-406.
  78

• 33.

  2007

  C. Ryan Miller; Howard L. McLeod

  Pharmacogenomics of cancer chemotheraphy-induced toxicity

  Journal of Supportive Oncology. 2007;5(1):9-14.
  15

• 34.

  2006

  C. Ryan Miller; Christopher P. Dunham; Bernd W. Scheithauer; Arie Perry

  Significance of necrosis in grading of oligodendroglial neoplasms: A clinicopathologic and genetic study of newly diagnosed high-grade gliomas

  Journal of Clinical Oncology. 2006;24(34):5419-5426.
  73

• 35.

  2005

  Charles Conrad; C. Ryan Miller; Yongjie Ji; Candeleria Gomez-Manzano; Suman Bharara; John S. McMurray; Frederick F. Lang; Franklin Wong; Raymond Sawaya; et al.

  Δ24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization

  Cancer Gene Therapy. 2005;12(3):284-294.
  32

• 36.

  2002

  Carmelo Blanquicett; G Yancey Gillespie; L Burt Nabors; C Ryan Miller; Sumen Bharara; Donald J Buchsbaum; Robert B Diasio; Martin R Johnson

  Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.

  Molecular cancer therapeutics. 2002;1(12):1139-1145.
  27

• 37.

  2002

  C.Ryan Miller; Allen N. Gustin; Donald J. Buchsbaum; Selwyn M. Vickers; Upender Manne; William E. Grizzle; Gretchen A. Cloud; Robert B. Diasio; Martin R. Johnson

  Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: A sensitive method for assessing 5-fluorocytosine toxicity in Vitro

  Analytical Biochemistry. 2002;301(2):189-199.
  5

• 38.

  2002

  C. Ryan Miller; Christopher R. Williams; Donald J. Buchsbaum; G. Yancey Gillespie

  Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas

  Cancer Research. 2002;62(3):773-780.
  59

• 39.

  2001

  J.A. Blumenthal; P. Arias; M. Babyak; T. Baldewicz; J. Barefoot; J. Bennett; P. Biles; R. Carels; E. Coleman; B. Crenshaw; et al.

  Enhancing recovery in coronary heart disease (ENRICHD): Baseline characteristics

  American Journal of Cardiology. 2001;88(3):316-322.
  40

• 40.

  2000

  F.J. Kelly; C.R. Miller; D.J. Buchsbaum; J. Gomez-Navarro; M.N. Barnes; R.D. Alvarez; D.T. Curiel

  Selectivity of tag-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro

  Clinical Cancer Research. 2000;6(11):4323-4333.
  54

• 41.

  1999

  Jerry L. Blackwell; C. Ryan Miller; Joanne T. Douglas; Hui Li; Paul N. Reynolds; William R. Carroll; Glenn E. Peters; Theresa V. Strong; David T. Curiel

  Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

  Archives of Otolaryngology - Head and Neck Surgery. 1999;125(8):856-863.
  53

• 42.

  1999

  Joanne T. Douglas; C. Ryan Miller; Myunghee Kim; Igor Dmitriev; Galina Mikheeva; Victor Krasnykh; David T. Curiel

  A system for the propagation of adenoviral vectors with genetically modified receptor specificities

  Nature Biotechnology. 1999;17(5):470-475.
  100

• 43.

  1999

  Diane L. Spencer; Scott A. Masten; Karah M. Lanier; Xinping Yang; Jean A. Grassman; Chris R. Miller; Thomas R. Sutter; George W. Lucier; Nigel J. Walker

  Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced cytochrome P450 1B1 expression in human lymphocytes

  Cancer Epidemiology Biomarkers and Prevention. 1999;8(2):139-146.
  52

• 44.

  1998

  C. Ryan Miller; Donald J. Buchsbaum; Paul N. Reynolds; Joanne T. Douglas; G. Yancey Gillespie; Matthew S. Mayo; David Raben; David T. Curiel

  Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer

  Cancer Research. 1998;58(24):5738-5748.
  278

• 45.

  1998

  Igor Dmitriev; Victor Krasnykh; C. Ryan Miller; Minghui Wang; Elena Kashentseva; Galina Mikheeva; Natalya Belousova; David T. Curiel

  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor- independent cell entry mechanism

  Journal of Virology. 1998;72(12):9706-9713.
  531

• 46.

  1998

  Victor Krasnykh; Igor Dmitriev; Galina Mikheeva; C. Ryan Miller; Natalya Belousova; David T. Curiel

  Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob

  Journal of Virology. 1998;72(3):1844-1852.
  217

• 47.

  1998

  P.N. Reynolds; C.R. Miller; C.K. Goldman; J. Doukas; B.A. Sosnowski; B.E. Rogers; J. Gomez-Navarro; G.F. Pierce; D.T. Curiel; J.T. Douglas

  Targeting adenoviral infection with basic fibroblast growth factor enhances gene delivery to vascular endothelial and smooth muscle cells

  Tumor Targeting. 1998;3(3):156-168.
  18

• 48.

  1996

  S.W. Ebbinghaus; N. Vigneswaran; C.R. Miller; R.A. Chee-Awai; C.A. Mayfield; D.T. Curiel; D.M. Miller

  Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexes

  Gene Therapy. 1996;3(4):287-297.
  11

• 49.

  1993

  John P. Vanden Heuvel; George C. Clark; Claudia L. Thompson; Zadock McCoy; Chris R. Miller; George W. Lucier; Douglas A. Bell

  CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes

  Carcinogenesis. 1993;14(10):2003-2006.
  104

• 50.

  1992

  D.A. Bell; C.L. Thompson; J. Taylor; C.R. Miller; F. Perera; L.L. Hsieh; G.W. Lucier

  Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: Application to glutathione transferase μ

  Environmental Health Perspectives. 1992;98:113-117.
  70